Centrum 7/6  banner

CEO

Health care outlook 2024: Ronald Piervincenzi, CEO, U.S. Pharmacopeia

Health care outlook 2024: Ronald Piervincenzi, CEO, U.S. Pharmacopeia

In the second of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The past year was significant for the pharmaceutical industry, as we witnessed major milestones and celebrated advancements in innovation. We saw an official end to the COVID-19 pandemic public health emergency and unlocked the potential

Health care outlook 2024: Sandra Hanna, CEO, Neighbourhood Pharmacies

Health care outlook 2024: Sandra Hanna, CEO, Neighbourhood  Pharmacies

In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. 2023 was a momentous year for community pharmacy in Canada. All provinces further expanded pharmacists’ scope of practice and/or increased

Health care outlook 2024: Lee Ann Stember, president and CEO, NCPDP

Health care outlook 2024: Lee Ann Stember, president and CEO,  NCPDP

In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review We are, without a doubt, at a tipping point with the current state of pharmacy practice. Drug shortages, staffing shortages,

Health care outlook 2024: Michael Hogue, CEO, APhA

Health care outlook 2024: Michael Hogue, CEO, APhA

In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. As the oldest national professional association for pharmacists, pharmacy technicians, student pharmacists and pharmaceutical scientists, the American Pharmacists Association touches

Spectrum Brands names new CEO

MIDDLETON, Wis. — Andreas Rouvé has been elected chief executive officer of Spectrum Brands Holdings Inc., succeeding Dave Lumley, who plans to retire from the company. Spectrum Brands said Monday that Rouvé, 53, is slated to take the CEO reins effective April 1. He has served as the consumer products company’s chief operating officer since

Neas to leave GPhA in the autumn

WASHINGTON — Ralph Neas, president and chief executive officer of the Generic Pharmaceutical Association, has announced he will step down from his position in the fall. Neas has led GPhA since September 2011. During his remaining tenure, he will continue to serve as CEO until a successor is named and will work to ensure a

Walgreens begins new phase in transformation

When the history of Walgreen Co. is written, Greg Wasson, who last month announced that he would step down as chief executive officer of the drug chain upon completion of its merger with Alliance Boots, will be seen as one of the company’s most consequential leaders. A product of the Walgreens system who joined the

PP_1170x120_10-25-21